STTR Phase I: Nanoengineered Encapsulation of Therapeutics

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0610751
Agency Tracking Number: 0610751
Amount: $100,000.00
Phase: Phase I
Program: STTR
Awards Year: 2006
Solicitation Year: 2006
Solicitation Topic Code: BT
Solicitation Number: NSF 05-605
Small Business Information
LNKChemsolutions
2411 Winchester South, Lincoln, NE, 68512
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: Y
Principal Investigator
 Gustavo Larsen
 Dr
 (402) 461-1811
 LNKChemsolutions@netscape.net
Business Contact
 Gustavo Larsen
Phone: (402) 416-1811
Email: LNKChemsolutions@netscape.net
Research Institution
 Argonne National Lab
 Luis Nunez
 9700 South Cass Avenue
Argonne, IL, 60439
 (630) 252-8230
 Domestic nonprofit research organization
Abstract
This Small Business Technology Transfer (STTR) Phase I project is a feasibility study for the design of true core-shell type nonocapsules for drug delivery. The research will focus on strategies aimed at controlling the nanostructure and chemistry of the capsules, and also on ways to design encapsulated therapeutics capable of being transported to specific parts of the body for targeted drug delivery. The capsule design strategy is rather general and the technology is expected to be portable to other therapeutic systems that may benefit from a similar delivery strategy. The research team expects to develop a commercial product line in the medium- and long-term, rather than a single encapsulated therapeutic. Market size is inferred from the number of patients per year the target encapsulated therapeutic is intended for. For the specific medical application, an upper limit of about l.5m patients per year in the US alone may benefit from new and improved drug delivery strategies.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government